Evonik Industries/€EVK

06:30
16:10
01:45
11:25
21:00
1D1W1MYTD1Y5YMAX

About Evonik Industries

Evonik Industries AG, a German multinational, specializes in producing specialty chemicals, primarily focusing on consumer goods, animal nutrition, and pharmaceuticals. Founded in 1873, the company operates globally and is structured into multiple segments including Specialty Additives, Nutrition & Care, and Smart Materials among others. As a publicly traded entity, it is listed on the Frankfurt Stock Exchange under the ticker EVK.

Ticker

€EVK
Sector
Materials

Primary listing

XETRA

Employees

31,273
Headquarters
Essen, Germany
Website
evonik.com

EVK Metrics

BasicAdvanced
€6.7B
70.23
€0.20
-
€1.17
8.15%

What the Analysts think about EVK

Analyst ratings (Buy, Hold, Sell) for Evonik Industries stock.

Bulls say / Bears say

Evonik’s first-quarter 2025 adjusted EBITDA increased 7% to €560 million, beating the €543 million consensus, thanks to strong growth in Nutrition & Care and disciplined cost controls, highlighting resilience in high-margin areas.
The May 2025 strategic plan targets a €1 billion core profit boost by 2027, split equally between €500 million in internal growth—using higher utilization at new plants and product innovation—and €500 million from efficiency improvements, providing a clear path to better margins.
The merger of Marl and Wesseling chemical services into Syneqt GmbH, scheduled for January 2026, will consolidate over €1.8 billion in annual revenue within one entity, which could improve operational efficiency and position the company for future partnerships or asset sales.
Evonik reduced its 2025 adjusted EBITDA outlook to about €1.9 billion, which is below its previous €2.0–2.3 billion range and the €1.96 billion consensus, due to ongoing weak demand that makes near-term earnings less predictable.
The company’s broad restructuring—including likely workforce cuts exceeding 20% and a two-year pause on acquisitions—suggests major internal challenges that could hurt employee morale and limit strategic options.
CEO Christian Kullmann cautioned that a possible economic slowdown in the second half of 2025, driven by U.S. protectionist trade policies and subdued global demand, increases the risk of revenue and margin declines.
Data summarised monthly by Lightyear AI. Last updated on 9 Oct 2025.

EVK Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

EVK Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €EVK

Sign up or log in to buy
Capital at risk
Extended hours trading

Upcoming events

No upcoming events
FAQs